Nashville-based Envision Healthcare shares plummeted by more than a third on Wednesday after the company posted lower-than-expected earnings and offered a weaker-than-expected fourth-quarter forecast.
Envision (NYSE: EVHC), which owns and operates hundreds of surgery centers, reported earnings of $40.7 million, or 73 cents per diluted share. While that's up compared to the $37.7 million of third-quarter earnings a year ago, it was below the 88 cents per share that analysts had expected. The company reported third-quarter revenue of $3.07 billion, which nearly tripled its year-ago figure.
As of 2:53 p.m. Wednesday, shares were trading at $28.25, down more than 33 percent for the day. The stock's 52-week range is $26.56 to $74.75.
Envision blamed some of the results on hurricanes Harvey and Irma, estimating a negative impact of $22 million on the quarter’s revenue. It also cited a decline in revenue that can be attributed to the Affordable Care Act amid continued uncertainty about the law.
“During the third quarter of 2017, our organization responded to a number of challenges, ranging from hurricanes that impacted two of our key markets to continued deceleration of health sector utilization following two years of heightened demand driven by coverage expansion,” Christopher Holden, Envision's president and CEO, said in a news release.
Envision’s fourth-quarter revenue forecast is 34 percent lower than analysts' expectations, at $1.88 billion to $2.02 billion, with an adjusted profit of between 44 cents and 54 cents per share.
In response, the company announced that its board of directors unanimously decided to initiate a “full review of a broad range of alternatives to enhance shareholder value.” The company said there is no timetable for completion of the strategic review and that it will not give updates on the review unless appropriate or required.
“While we have made considerable progress in building the new Envision around a set of highly-differentiated physician-centric clinical solutions, the board believes that a review at this time — with all options on the table, including continuing to execute on our strategic plan — is in the best interests of Envision shareholders,” William Sanger, chairman of the board of directors, said in the release.
The move comes less than a year after Envision merged with AmSurg to create one of the largest health care providers in the country. The company has also made several acquisitions this year. Prior to Tuesday’s report, the company had been meeting its earnings targets.
Richard Close, a health care analyst with Canaccord Genuity, called the earnings report “very disappointing” and said the fourth-quarter projections were alarming. However, Close said he expects Envision — which he called "the market leader" — to bounce back. Close added that he is "encouraged that the company understands that the need to address the poor operational results and evaluate strategies to deliver shareholder returns.”